_version_ |
1797285887341494272
|
collection |
DOAJ
|
first_indexed |
2024-03-07T18:09:54Z
|
format |
Article
|
id |
doaj.art-b24235581e774f3097cbfd448550a4d2
|
institution |
Directory Open Access Journal
|
issn |
2572-9241
|
language |
English
|
last_indexed |
2024-03-07T18:09:54Z
|
publishDate |
2018-10-01
|
publisher |
Wiley
|
record_format |
Article
|
series |
HemaSphere
|
spelling |
doaj.art-b24235581e774f3097cbfd448550a4d22024-03-02T07:47:34ZengWileyHemaSphere2572-92412018-10-012474810.1097/01.HS9.0000547963.21253.ef201810003-00120P119 (0078) REAL LIFE DATA OF BRENTUXIMAB VEDOTIN USE IN RELAPSED/REFRACTORY HL IN SWEDENhttp://journals.lww.com/10.1097/01.HS9.0000547963.21253.ef
|
spellingShingle |
P119 (0078) REAL LIFE DATA OF BRENTUXIMAB VEDOTIN USE IN RELAPSED/REFRACTORY HL IN SWEDEN
HemaSphere
|
title |
P119 (0078) REAL LIFE DATA OF BRENTUXIMAB VEDOTIN USE IN RELAPSED/REFRACTORY HL IN SWEDEN
|
title_full |
P119 (0078) REAL LIFE DATA OF BRENTUXIMAB VEDOTIN USE IN RELAPSED/REFRACTORY HL IN SWEDEN
|
title_fullStr |
P119 (0078) REAL LIFE DATA OF BRENTUXIMAB VEDOTIN USE IN RELAPSED/REFRACTORY HL IN SWEDEN
|
title_full_unstemmed |
P119 (0078) REAL LIFE DATA OF BRENTUXIMAB VEDOTIN USE IN RELAPSED/REFRACTORY HL IN SWEDEN
|
title_short |
P119 (0078) REAL LIFE DATA OF BRENTUXIMAB VEDOTIN USE IN RELAPSED/REFRACTORY HL IN SWEDEN
|
title_sort |
p119 0078 real life data of brentuximab vedotin use in relapsed refractory hl in sweden
|
url |
http://journals.lww.com/10.1097/01.HS9.0000547963.21253.ef
|